Related Experiment Video
Updated: May 23, 2026

04:42
Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
Published on: June 26, 2018
Spinal cord stimulation for refractory angina pectoris -a case report-
Seong Heon Lee1, Hye Jin Jeong, Sin Ho Jeong
1Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School, Gwangju, Korea.
The Korean Journal of Pain
|April 20, 2012
Summary
Spinal cord stimulation effectively relieved chest pain in a patient with refractory angina pectoris. This minimally invasive neuromodulation offers a new treatment option for patients with coronary artery disease unresponsive to conventional therapies.
Area of Science:
- Cardiology
- Neuromodulation
- Interventional Cardiology
Background:
- Refractory angina pectoris (RAP) is characterized by chest pain unresponsive to optimal medical treatment and revascularization.
- Current treatment strategies for RAP remain inadequate, posing a significant clinical challenge.
- Spinal cord stimulation (SCS) is an emerging neuromodulatory technique for pain management.
Observation:
- A 40-year-old male patient with coronary artery disease presented with refractory angina pectoris.
- The patient underwent spinal cord stimulation, a minimally invasive procedure involving epidural electrode implantation.
- This case represents the first reported instance of SCS for RAP in South Korea.
Findings:
- Spinal cord stimulation demonstrated significant efficacy in alleviating chest pain in the patient with RAP.
- The SCS procedure was well-tolerated, indicating a favorable safety profile.
- Neuromodulation via SCS provided substantial relief from ischemic chest pain.
Implications:
- Spinal cord stimulation presents a promising, minimally invasive therapeutic option for patients with refractory angina pectoris.
- This case highlights the potential of SCS as a viable treatment for refractory angina, particularly in cases resistant to standard interventions.
- Further research and clinical application of SCS in South Korea could expand treatment possibilities for cardiovascular patients.

